Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of Neonatal Abstinence Syndrome

Trial Profile

Prevention of Neonatal Abstinence Syndrome

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 May 2013

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Nausea; Neonatal-disorders
  • Focus Pharmacokinetics
  • Acronyms Zofran-PK
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top